Search results
30 wrz 2024 · This community-based randomized clinical trial integrated H pylori stool antigen (HPSA) screening and treatment with fecal immunochemical testing (FIT) screening to determine whether an invitation to HPSA + FIT could reduce the incidence and mortality of gastric cancer compared with use of FIT alone. Methods.
29 sie 2022 · In this systematic review, we aimed to examine the relationship between H. pylori infection and pancreatic cancer based on the evidence from the existing observational studies across the world.
1 sty 2018 · Helicobacter pylori (H pylori) is a spiral-shaped, flagellated, micro-aerophilic gram-negative bacillus that colonizes the gastric mucosa of more than 50% of the human population.
H. pylori infection usually persists for life, unless it is treated with antibiotics or autoeradication occurs when long-standing infection causes widespread gastric mucosal atrophy and metaplasia with achlorhydria.
1 sty 2017 · Levofloxacin-based triple therapy, furazolidone-based regimens, and recent hybrid or rescue therapies are also beneficial towards the eradication of H. pylori infection as a second or third line...
19 sie 2023 · H. pylori infection is the most severe known risk factor for gastric cancer (GC), which is the second highest cause of cancer-related deaths globally. We conducted a systematic review and meta-analysis to assess the global prevalence of GC in H. pylori-infected individuals.
20 kwi 2023 · The risk of gastric cancer is highest in individuals who have infection by more virulent H. pylori strains, have pro-inflammatory host genetic factors, poor diet (high salt, smoked foods),...
